Pembrolizumab as First-Line Therapy in Programmed Death Ligand 1-Positive Advanced Lung Cancer: Is It as Effective as We Think It Is?
Cancer - United States
doi 10.1002/cncr.30868
Full Text
Open PDFAbstract
Available in full text
Date
June 29, 2017
Authors
Publisher
Wiley